Pneumococcal meningitis during therapy of otitis media with clarithromycin.
Reid
R
R
University of California, San Diego, USA.
Bradley
J S
JS
Hindler
J
J
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology*; D002555:Cerebrospinal Fluid / Q000382:microbiology; D017291:Clarithromycin / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D008586:Meningitis, Pneumococcal / Q000188:drug therapy / Q000209:etiology*; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D010033:Otitis Media / Q000150:complications / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013845:Thienamycins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D013845:Thienamycins; D003907:Dexamethasone; D000077731:Meropenem; D017291:Clarithromycin